NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 185)
Posted On: 04/19/2022 4:00:54 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at Sequire Cannabis & Psychedelics Conference
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a presenter at the Sequire Cannabis & Psychedelics Investor Conference. The virtual event, taking place on April 20, 2022, will feature over 30 top public companies in the cannabis and psychedelics space. PBI’s president and CEO Richard T. Schumacher is scheduled to present, beginning at 10:30 a.m. ET, and will expand on the company’s recent achievements in the nanoemulsification of CBD and other cannabinoids, as well as with a variety of oil-based, hydrophobic active ingredients used in biopharmaceutical, cosmetics, agrochemical, health and wellness, and food/beverage areas. Schumacher will also expand on PBI’s planned fall 2022 commercialization of its revolutionary Ultra Shear Technology(TM) (UST(TM)) nanoemulsification platform.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biopharmaceuticals and other industries, today announced its participation as a presenter at the Sequire Cannabis & Psychedelics Investor Conference. The virtual event, taking place on April 20, 2022, will feature over 30 top public companies in the cannabis and psychedelics space. PBI’s president and CEO Richard T. Schumacher is scheduled to present, beginning at 10:30 a.m. ET, and will expand on the company’s recent achievements in the nanoemulsification of CBD and other cannabinoids, as well as with a variety of oil-based, hydrophobic active ingredients used in biopharmaceutical, cosmetics, agrochemical, health and wellness, and food/beverage areas. Schumacher will also expand on PBI’s planned fall 2022 commercialization of its revolutionary Ultra Shear Technology(TM) (UST(TM)) nanoemulsification platform.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼